Florida International University
Edit Your Profile
FIU Discovery
Toggle navigation
Browse
Home
People
Organizations
Scholarly & Creative Works
Research Facilities
Support
Edit Your Profile
ALZHEIMERS & DEMENTIA
Journal
Overview
Research
Identifiers
View All
Overview
publication venue for
Plasma Alzheimer's biomarkers and brain amyloid in Hispanic and non-Hispanic older adults
. 20:437-446.
2024
Age‐ and Sex‐ dependent changes in Translocator Protein 18 kDa (TSPO) expression, cellular sources, and association with amyloid‐β plaques in the 5XFAD murine model of Alzheimer’s Disease
. 19.
2023
Applying Implementation Frameworks to Health IT Development in Dementia Care: Lessons from the CareHeroes Project
. 19.
2023
Applying Implementation Frameworks to Health IT Development in Dementia Care: Lessons from the CareHeroes Project
. 19.
2023
Plasma Alzheimer’s Disease Biomarkers and Brain Amyloid in a Multi‐Ethnic Aging Cohort
. 19.
2023
The relationship between Structural, PET, and Plasma Alzheimer’s Disease Biomarkers and neuropsychological composites among Latino bilinguals and monolinguals
. 19.
2023
The pharmaceutical potential of AR‐65, a novel Alzheimer’s disease drug targeting the immunoproteasome
. 18.
2022
Differential discordance of informant‐ and self‐rated depression and apathy in Black, Hispanic, and White participants in the NACC dataset
. 17.
2021
Identifying veterans at risk for dementia using claims‐based electronic health record data and machine learning
. 17.
2021
Recruitment and retention of culturally diverse older adults into aging research: Investigation planning to explore intergenerational influence
. 17.
2021
Age‐friendly initiative needs assessment survey: Los Angeles City and County employees
. 16.
2020
Reduced cortical thickness in World Trade Center responders with cognitive impairment
. 16.
2020
P1‐153: DDT EXPOSURE INCREASES LEVELS OF THE AMYLOID PRECURSOR PROTEIN, AMYLOID BETA, AND PROINFLAMMATORY FACTORS: MECHANISTIC LINKS TO ALZHEIMER'S DISEASE RISK
. 15:p295-p295.
2019
P2‐427: THE RELATIONSHIP BETWEEN HISPANIC ETHNICITY, AMYLOID LOAD AND APOE4 CARRIER STATUS
. 15:p775-p776.
2019
P4‐220: EVALUATION OF RESERVE AND RESILIENCE IN THE OLDER SURGICAL PATIENT
. 15:p1360-p1361.
2019
P4‐680: A SELECTIVE INHIBITOR OF THE IMMUNOPROTEASOME ATTENUATES DISEASE PROGRESSION IN MOUSE MODELS OF ALZHEIMER'S DISEASE
. 15:p1592-p1592.
2019
P1‐365: THE ASSOCIATION OF DEPRESSIVE SYMPTOMS, APATHY, AND ANTIDEPRESSANT USE WITH INCIDENT MCI AND DEMENTIA IN THE NACC DATASET
. 14:p434-p435.
2018
P2‐383: CONVERGENCE ANALYSIS OF MICRO‐LESIONS (CAML) FOR DIFFUSE PATHOLOGIES
. 14:p844-p845.
2018
P3‐378: EFFECT OF AGE, GENDER, ETHNICITY, COGNITION AND APOE GENOTYPE ON AMYLOID LOAD AMONG NORMAL, MCI AND MILD DEMENTIA SUBJECTS USING [F‐18] FLORBETABEN
. 14:p1237-p1238.
2018
[P1–421]: OPTIMAL NEUROIMAGING MEASURES FOR TRACKING ALZHEIMER's DISEASE PROGRESSION
. 13:p438-p440.
2017
[P2–422]: PREDICTING COGNITIVE TEST SCORES IN ALZHEIMER's PATIENTS USING MULTIMODAL LONGITUDINAL DATA
. 13:p796-p797.
2017
[P3–554]: PERSISTENT DEPRESSIVE SYMPTOMS AS PARTIAL MEDIATORS IN THE ASSOCIATIONS BETWEEN SUBCLINICAL CARDIOVASCULAR DISEASE WITH ONSET OF MILD COGNITIVE IMPAIRMENT AND DEMENTIA
. 13:p1190-p1191.
2017
P3‐190: Relationship between Serum Pesticide Levels and Cognitive Function in Elderly Individuals in the United States: Race/Ethnicity Differences
. 12:p894-p894.
2016
P3‐241: Conceptualizing and Individually Predicting Behavioural Variant Frontotemporal Dementia with Meta‐Analyses and Pattern Classification of Imaging Data
. 12:p919-p919.
2016
P4‐364: Depressive Symptoms as Potential Mediators of the Associations of Vascular Burden and Subclinical Cardiovascular Disease with Cognitive Decline: Cardiovascular Health Study
. 12:p1176-p1177.
2016
O2‐03‐01: Vitamin D and decline in global cognition and memory in the cardiovascular health study
. 11:p177-p178.
2015
O2‐03‐02: Vitamin D and the risk of developing neuroimaging abnormalities
. 11:p178-p178.
2015
P3‐168: Progression rates from mild cognitive impairment to dementia by biomarker and memory thresholds
. 11:p693-p694.
2015
P4‐071: Progression rates to incident mild cognitive impairment by biomarker and memory thresholds
. 11:p796-p797.
2015
IC‐P‐003: RELATIONSHIP OF MEDIAL TEMPORAL VOLUME TO MEAN BRAIN AMYLOID CONCENTRATION, APOE GENOTYPE, AND DISEASE STAGE IN ADNI
. 10:p8-p9.
2014
IC‐P‐004: THRESHOLDS FOR BRAIN AMYLOID CONCENTRATION IN RELATION TO DISEASE STAGE, COGNITION, BRAIN METABOLISM, BRAIN ATROPHY, AND APOE GENOTYPE IN THE ADNI COHORT
. 10:p9-p9.
2014
P4–394: Vitamin D and incident Alzheimer's disease in the Cardiovascular Health Cognition Study
. 9:p880-p880.
2013
O4‐07‐03: Pivotal role of the RanBP9‐Cofilin pathway in Aß‐induced apoptosis and neurodegeneration
. 8:p627-p628.
2012
P3‐128: A DDT metabolite is elevated in the serum of Alzheimer's disease patients
. 8:p496-p496.
2012
O4‐02‐02: Role of the LRP‐RanBP9 pathway in APP processing and Alzheimer's disease susceptibility
. 5:p151-p152.
2009
Hypothesis: JNK signaling is a therapeutic target of neurodegenerative diseases
2022
Research
category
CLINICAL NEUROLOGY
Category
Identifiers
International Standard Serial Number (ISSN)
1552-5260